InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Smith Justin Adam, Director. Officer active across 1 company, notably Journey Medical Corp. Cumulatively, 7 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €189k. Activity tracked since 14 January 2022. The latest transaction was disclosed on 8 July 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
7 of 7 declarations
Justin Adam Smith is a Director at Journey Medical Corp. In this role, he participates in overseeing the company's operations, which focuses on developing innovative medical solutions. Justin brings significant expertise in the healthcare field, enriching strategic discussions within the board.